Neuro Event Labs wins CMS NTAP coverage for Nelli seizure monitoring system, up to USD 975 per case

• Hadean Ventures portfolio company Neuro Event Labs secured CMS NTAP coverage for Nelli seizure monitoring in fiscal 2027.
• Eligible Medicare inpatient cases using Nelli can receive up to USD 975 extra per case from Oct. 1, 2026.
• Decision follows FDA 510(k) clearance in November 2025 for Nelli, a video-based, AI-powered seizure monitoring system.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hadean Ventures AS published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.